Recce Pharmaceuticals Ltd Announces Appointment of Philip Sutton to Their Clinical Advisory Committee and Head of the Helicobacter Pylori (H. Pylori) Stomach Bacteria Development Program
August 21, 2020 at 12:26 am EDT
Recce Pharmaceuticals Ltd. announced the appointment of Professor Philip Sutton to their Clinical Advisory Committee and Head of the Helicobacter pylori (H. pylori) stomach bacteria development program. Professor Sutton brings more than 30 years of research and industry experience in immunology, inflammatory disease and H. pylori bacteria, having served as the former Head of Immunology at CSL Limited in Melbourne.